SAMSUNG
LIVE

Serial Number

79251914

Owner

Samsung C&T Corporation

Attorney

Daniel I. Schloss

Filing Date

Sep 17, 2018

Add to watchlist:

No watchlists yet
View on USPTO

SAMSUNG Trademark

Serial Number: 79251914 • Registration: 5899721

SAMSUNG is a trademark filed by Samsung C&T Corporation on September 17, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 11 (Environmental Control), Class 12 (Vehicles), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Samsung C&T Corporation

26, Sangil-ro 6-gil, Gangdong-gu
Seoul 05288 , KR

Entity Type: 03

Trademark Details

Filing Date

September 17, 2018

Registration Date

November 5, 2019

Published for Opposition

August 20, 2019

Goods & Services

Medical information services provided via the internet; medical and pharmaceutical consultation; hygienic and beauty care for humans and animals; cosmetic and medical services for the care of the skin; dentistry services; conducting physical examination for medical purposes; hospital services; medical clinics; telemedicine services; providing health information; medical equipment rental; conducting physical examination for medical purposes via the internet

[ Sterilizing device for hospitals, namely, sterilizers, air sterilizers, water sterilizers, ultraviolet sterilizers, ultrasonic sterilizers ]

Respiration monitors; apparatus for monitoring patients and analyzing arrhythmias, namely, medical apparatus for monitoring vital signs of patients; equipment for respiratory technology, namely, respiratory masks for medical purposes; apparatus for the treatment of deafness for hearing-impaired children, namely, cochlear implants; medical hearing and speaking equipment for the hearing-impaired children, namely, hearing aids, assistive listening devices for the hearing impaired, transmitters and receivers for use with hearing aids for the deaf and hard of hearing; medical equipment for the hard of hearing, for diagnosis and therapy purposes, namely, audiometers, hearing aids for the deaf, therapeutic instruments in the nature of hearing aids for the hearing impaired, assistive listening devices for the hearing impaired, and hearing amplifiers for medical use; equipment for the localization of tumours, namely, mammography apparatus in the nature of medical image processors, linear accelerators for tumor radiotherapy, tumor localization devices for medical purposes, and dosage planning devices being drug delivery devices and systems for tumor radiotherapy; apparatus, namely, drug delivery devices and systems for dosage planning and the documentation of tumour radiotherapy; radiotherapy apparatus, namely, linear accelerators for tumour radiotherapy; medical apparatus and equipment for recording, processing, storing and reproducing medical images, namely, medical imaging apparatus, medical x-ray apparatus medical ultrasound apparatus, medical imaging transducers; point-of-care diagnostic apparatus, equipment and instruments for medical purposes, namely, portable health monitoring devices comprised of monitors, sensors, and detectors that detect health conditions and diseases in the nature of cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; protective devices and protective screens for protecting against exposure to x-rays, all for medical purposes, namely, patient x-ray radiation shields, x-ray aprons, x-ray shields, lead gloves, medical safety glasses; apparatus for ECG long-term storage and computerized ECG evaluation electroencephalography, namely, electrocardiographs, electrocardiograph recorders, and electrocardiograph apparatus incorporating medical computer software to record, process and analyze ECG data; electro-medical apparatus and equipment for x-ray diagnostics and x-ray therapy, namely, x-ray diagnostic apparatus for medical purposes; medical equipment for digital image recording, for contrast medium analysis with real time image reproduction, namely, electromagnetic medical diagnostic imaging apparatus; urine analysis apparatus for medical purposes; measuring apparatus for cardiac catheterization for medical purposes; medical x-ray CT scanners; peripheral devices of medical CT scanners, namely, integral component of the image chain of a CT scanner for capturing X-rays and converting them to information that creates the image; dental x-ray CT scanners; structural parts and fittings of dental x-ray CT scanners; magnetic resonance imaging (MRI) apparatus for medical purposes; gloves for medical purposes; patient monitoring sensors and alarms; biometric medical scanners for health check and diagnosis, namely, sensors for medical use to be worn by a human to gather human biometric data; biometric identification medical apparatus for health check and diagnosis, namely, sensors for medical use to be worn by a human to gather human biometric data

Connected vehicles, namely, land vehicles connected to internet; driverless cars being autonomous cars; structural parts and fittings for autonomous vehicles; electric reversing alarms for vehicle incorporating parking assistance apparatus with foreview and rearview sensors, namely, back-up warning alarms for vehicles; anti-theft warning apparatus for motor cars with software and hardware for internet of things

Pharmaceutical products for the treatment of colorectal cancer; biopharmaceuticals for the treatment of cancer; antibodies for medical purposes; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceuticals, biosimilars and biological preparations for medical purposes for treatment of cancer, immunologic disorders, autoimmune diseases, arthritis, inflammatory diseases, central nervous system disorders, and metabolic diseases; pharmaceutical preparations for the treatment of leukemia; vaccines against pneumococcal infections; pharmaceutical preparations for ocular use; pharmaceutical drug, namely, pharmaceutical preparations for the treatment of anemia; biochemical preparations for medical purpose for the treatment of cancer, immunologic disorders, autoimmune diseases, arthritis, inflammatory diseases, central nervous system disorders, and metabolic diseases; nutraceutical preparations for therapeutic or medical purposes for the treatment of cancer, immunologic disorders, autoimmune diseases, arthritis, inflammatory diseases, central nervous system disorders, and metabolic diseases; nutraceuticals for use as dietary supplements

Filing History

OFFICE ACTION ISSUED POU1
Jun 2, 2026 PUM1
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 5, 2026 APRE
TEAS SECTION 71 RECEIVED
May 4, 2026 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 5, 2024 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Mar 19, 2022 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Jul 16, 2020 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jun 18, 2020 NREP
LIMITATION FROM THE IB EXAMINED AND ENTERED
Apr 1, 2020 LIME
CORRECTION UNDER SECTION 7 - PROCESSED
Apr 1, 2020 COC.
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 21, 2020 FINO
LIMITATION OF GOODS RECEIVED FROM IB
Mar 13, 2020 LIMG
FINAL DISPOSITION NOTICE SENT TO IB
Mar 4, 2020 FICS
FINAL DISPOSITION PROCESSED
Mar 3, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 5, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 5, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 20, 2019 NPUB
PUBLISHED FOR OPPOSITION
Aug 20, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Aug 16, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 31, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 31, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 31, 2019 NONP
ASSIGNED TO LIE
Jul 12, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 1, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 17, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 17, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 17, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 17, 2019 CNEA
NEW REPRESENTATIVE AT IB RECEIVED
Jun 6, 2019 NREP
TEAS/EMAIL CORRESPONDENCE ENTERED
May 29, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 28, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 28, 2019 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 27, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 27, 2019 REAP
REFUSAL PROCESSED BY IB
Mar 23, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 6, 2019 RFCS
REFUSAL PROCESSED BY MPU
Mar 6, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 26, 2019 RFCR
APPLICATION FILING RECEIPT MAILED
Feb 26, 2019 MAFR
NON-FINAL ACTION WRITTEN
Feb 25, 2019 CNRT
ASSIGNED TO EXAMINER
Feb 20, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 20, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 14, 2019 REPR